Loading...
Indian Pharmaceutical Exporter · #1 for Bevacizumab · $6.5M export value · DGFT Verified
Dr.reddy's Laboratories Ltd is the #1 Indian exporter of Bevacizumab with $6.5M in export value and 131 verified shipments. Dr.reddy's Laboratories Ltd holds a 14.0% market share in Bevacizumab exports across 15 countries.
| SOUTH AFRICA |
| $144.5K |
| 5 |
| 2.9% |
| UNITED KINGDOM | $111.3K | 6 | 2.2% |
| KENYA | $86.9K | 2 | 1.7% |
| POLAND | $82.5K | 5 | 1.7% |
| MAURITIUS | $63.2K | 3 | 1.3% |
| ALGERIA | $16.3K | 5 | 0.3% |
Dr.reddy's Laboratories Ltd exports Bevacizumab to 15 countries. The largest destination is RUSSIA accounting for 51.0% of Dr.reddy's Laboratories Ltd's Bevacizumab shipments, followed by COLOMBIA (26.9%) and THAILAND (5.9%). These destinations reflect Dr.reddy's Laboratories Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| JSC R-PHARM | RUSSIA | $2.5M | 51 |
| DR.REDDYS LABORATORIES SAS | COLOMBIA | $937.1K | 20 |
| DR. REDDYS LABORATORIES SAS | COLOMBIA | $408.2K | 9 |
| STATE TRADING ORGANIZATION PLC | MALDIVES | $115.6K | 5 |
| MOVIANTO UK LIMITED | UNITED KINGDOM | $111.3K | 6 |
| STATE TRADING ORGANIZATION PLC. | MALDIVES | $108.9K | 4 |
| DR.REDDYS LABORATORIES(PTY)LTD, | SOUTH AFRICA | $100.0K | 2 |
| DR. REDDY'S LABORATORIES (THAILAND) | THAILAND | $88.1K | 3 |
| DR. REDDYS LABORATORIES (THAILAND) | THAILAND | $83.9K | 3 |
| SELVTIA SERVICES SP.Z O.O. | POLAND | $82.5K | 5 |
Dr.reddy's Laboratories Ltd supplies Bevacizumab to 26 buyers globally. The largest buyer is JSC R-PHARM (RUSSIA), followed by DR.REDDYS LABORATORIES SAS (COLOMBIA) and DR. REDDYS LABORATORIES SAS (COLOMBIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $15.2M worth of Bevacizumab through 1,408 shipments from 196 suppliers to 100 countries, serving 346 buyers globally. Dr.reddy's Laboratories Ltd contributes $6.5M to this total, accounting for 14.0% of India's Bevacizumab exports. Dr.reddy's Laboratories Ltd ships Bevacizumab to 15 countries through 26 buyers.
Dr.reddy's Laboratories Ltd's average Bevacizumab shipment value is $50.0K per consignment, based on 131 shipments totaling $6.5M. The largest destination is RUSSIA (51.0% of Dr.reddy's Laboratories Ltd's Bevacizumab exports).
Dr.reddy's Laboratories Ltd ranks #1 among 196 Indian Bevacizumab exporters with a 14.0% market share. The top 3 exporters are DR.REDDY'S LABORATORIES LTD ($6.5M), BIOCON BIOLOGICS INDIA LIMITED ($2.3M), RELIANCE LIFE SCIENCES PRIVATE LIMITED ($2.1M). Dr.reddy's Laboratories Ltd processed 131 shipments to 15 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CO | $1.1M | 22 |
| PERSIVIA 100MG/4ML(BEVACIZUMAB(1S))(QTY: | $250.0K | 5 |
| PERSIVIA 100MG/4ML(BEVACIZUMAB)[1S](QTY: | $150.0K | 3 |
| VERSAVO 100MG (BEVACIZUMAB) | $122.5K | 5 |
| BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 34.0 MG/ML WITH BUFFER SOLUTION 28,404 L(QTY:965.736 GMS) | $100.0K | 2 |
| BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 36.0 MG/ML WITH BUFFER SOLUTION 28,040 L(QTY:1009.440 GMS) | $100.0K | 2 |
| VERSAVO 100MG (BEVACIZUMAB)VLS | $62.7K | 2 |
| VERSAVO 100MG(BEVACIZUMAB)(QTY:1000 VIALS) | $59.5K | 2 |
| PERSIVIA 100MG/4ML 1S (BEVACIZUMAB)(QTY:1011 VIALS)VLS | $50.0K | 1 |
| PERSIVIA 100MG/4ML (1S) (BEVACIZUMAB)(QTY:770 VIALS)VLS | $50.0K | 1 |
Dr.reddy's Laboratories Ltd exports 103 distinct Bevacizumab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CO with 22 shipments worth $1.1M.
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD ★ | $6.5M | 131 | 15 | $50.0K |
| 2 | BIOCON BIOLOGICS INDIA LIMITED | $2.3M | 46 | 12 | $50.0K |
| 4 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $2.1M | 73 | 12 | $29.1K |
Dr.reddy's Laboratories Ltd ranks #1 among 196 Indian Bevacizumab exporters. Average shipment value of $50.0K compared to the market average of $77.5K. The closest competitors by value are BIOCON BIOLOGICS INDIA LIMITED and RELIANCE LIFE SCIENCES PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 345 | 24.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 327 | 23.2% |
| HYDERABAD ACC (INHYD4) | 132 | 9.4% |
| Bombay Air | 89 | 6.3% |
| DELHI AIR CARGO ACC (INDEL4) | 48 | 3.4% |
| DELHI AIR | 47 | 3.3% |
| HYDERABAD AIR | 36 | 2.6% |
| AHEMDABAD AIR | 32 | 2.3% |
Latest developments and market context
Detailed market intelligence for Bevacizumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 346+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dr.reddy's Laboratories Ltd's Bevacizumab exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Dr.reddy's Laboratories Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Dr.reddy's Laboratories Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bevacizumab. For current shipment-level data, contact TransData Nexus.